npj Vaccines is a multidisciplinary journal that is dedicated to publishing the finest and high-quality research and development on human and veterinary vaccines.
Esoteric attitudes—especially with regard to complementary and alternative medicine—have an influence on the willingness to be vaccinated. Dr. Sebastian Jäckle and Dr. James K. Timmis, both from the Department of Political ...
Sep 5, 2024
0
1
Research led by University of Oxford researchers describes a first-of-its-kind method capable of distinguishing authentic and falsified vaccines by applying machine learning to mass spectral data. The method proved effective ...
Aug 29, 2024
0
19
A new vaccine against cancer-causing human papillomaviruses (HPV) is intended to help increase the rate of HPV vaccinations, particularly in developing countries. Scientists at the German Cancer Research Center (DKFZ) have ...
Aug 14, 2024
0
14
Researchers from the University of Liverpool's Center for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA vaccines.
Jul 18, 2024
0
17
A vaccine against Zika virus is safe and effective when administered both before and during pregnancy, according to new research published in npj Vaccines.
Mar 4, 2024
0
12
Since the beginning of the COVID-19 pandemic, Raghavan Varadarajan, Professor at the Molecular Biophysics Unit (MBU), Indian Institute of Science (IISc), and collaborators have been working on developing a heat-tolerant vaccine ...
Jan 11, 2024
0
35
Nearly two in five U.S. adults have high cholesterol, according to the Centers for Disease Control and Prevention (CDC). Untreated, high cholesterol can lead to heart disease and stroke, which are two of the top causes of ...
Dec 18, 2023
1
160
Researchers at the University of Montana and their partners are nearing human trials for vaccines to prevent fentanyl and heroin drug overdoses.
Aug 29, 2023
1
71
Professor Bernd Rehm and Dr. Shuxiong Chen from the Griffith Institute for Drug Discovery (GRIDD) and Griffith's Center for Cell Factories and Biopolymers have succeeded in developing a new vaccine modality that is a stable ...
Aug 24, 2023
0
21
